Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
164.36
-5.61 (-3.30%)
Nov 13, 2026, 4:00 PM EST - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.62 billion as of November 13, 2026. It is the 2,899th most valuable company in the world and the 971st biggest in the United States. Its market cap has increased by 71.19% in one year.
Market Cap
6.62B
Enterprise Value
6.13B
1-Year Change
71.19%
Global Rank
Country Rank
#971 United States
Category
ChartMarket Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.62B, an increase of 4,478.30%. That is a compound annual growth rate of 131.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 6.62B | 10.30% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 7.45B |
| Kodiak Sciences | 7.26B |
| Oruka Therapeutics | 7.15B |
| Immunovant | 7.07B |
| Twist Bioscience | 7.00B |
| Arrowhead Pharmaceuticals | 6.75B |
| CG Oncology | 6.65B |
| Caris Life Sciences | 6.61B |